Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.

Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.

Näytä muut versiot (1)

Benzodiazepines are psychoactive drugs with anxiolytic, sedative, skeletal muscle relaxant and amnestic properties. Recently triazolo-benzodiazepines have been also described as potent and highly selective protein interaction inhibitors of bromodomain and extra-terminal (BET) proteins, a family of t...

Bibliografiset tiedot
Päätekijät:	Filippakopoulos, P, Picaud, S, Fedorov, O, Keller, M, Wrobel, M, Morgenstern, O, Bracher, F, Knapp, S
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2012

Samankaltaisia teoksia

Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family
Tekijä: Filippakopoulos, P, et al.
Julkaistu: (2012)

The design and synthesis of 5-and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains
Tekijä: Hay, D, et al.
Julkaistu: (2013)

Chemical probes for bromodomains outside the BET family
Tekijä: Brennan, P, et al.
Julkaistu: (2013)

Developing chemical probes for the BET bromodomains
Tekijä: Hewings, D, et al.
Julkaistu: (2012)

PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.
Tekijä: Picaud, S, et al.
Julkaistu: (2013)

RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.
Tekijä: Picaud, S, et al.
Julkaistu: (2013)

RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
Tekijä: Picaud, S, et al.
Julkaistu: (2013)

Selective inhibition of BET bromodomains.
Tekijä: Filippakopoulos, P, et al.
Julkaistu: (2010)

Selective inhibition of BET bromodomains.
Tekijä: Filippakopoulos, P, et al.
Julkaistu: (2010)

Stimulation of Hepatic Apolipoprotein A-I Production by Novel Thieno-Triazolodiazepines: Roles of the Classical Benzodiazepine Receptor, PAF Receptor, and Bromodomain Binding.
Tekijä: Kempen, H, et al.
Julkaistu: (2013)

Discovery of BET bromodomain inhibitors and their role in target validation
Tekijä: Mueller, S, et al.
Julkaistu: (2014)

Synthesis and biological investigation of (+)-JD1, an organometallic BET bromodomain inhibitor
Tekijä: Hassell-Hart, S, et al.
Julkaistu: (2019)

Interactome rewiring following pharmacological targeting of BET bromodomains
Tekijä: Lambert, J-P, et al.
Julkaistu: (2018)

Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.
Tekijä: Philpott, M, et al.
Julkaistu: (2011)

Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.
Tekijä: Philpott, M, et al.
Julkaistu: (2011)

Chemical probes and inhibitors of bromodomains outside the BET family
Tekijä: Moustakim, M, et al.
Julkaistu: (2016)

Evaluation of linker length effects on a BET bromodomain probe
Tekijä: Traquete, R, et al.
Julkaistu: (2019)

Promiscuous targeting of bromodomains by Bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia
Tekijä: Picaud, S, et al.
Julkaistu: (2016)

Bromodomains as therapeutic targets.
Tekijä: Muller, S, et al.
Julkaistu: (2011)

Small-molecule bromodomain inhibitors for cancer therapy
Tekijä: Qi, J, et al.
Julkaistu: (2010)

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.
Tekijä: Ciceri, P, et al.
Julkaistu: (2014)

Targeting bromodomains: epigenetic readers of lysine acetylation.
Tekijä: Filippakopoulos, P, et al.
Julkaistu: (2014)

Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma
Tekijä: Cheng, Z, et al.
Julkaistu: (2013)

Inhibition of BET bromodomain targets genetically diverse glioblastoma.
Tekijä: Cheng, Z, et al.
Julkaistu: (2013)

Corrigendum: Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.
Tekijä: Ciceri, P, et al.
Julkaistu: (2014)

Effect of BET missense mutations on bromodomain function, inhibitor binding and stability
Tekijä: Lori, L, et al.
Julkaistu: (2016)

Development of selective CBP/P300 benzoxazepine bromodomain inhibitors
Tekijä: Popp, T, et al.
Julkaistu: (2016)

Effect of BET Missense Mutations on Bromodomain Function, Inhibitor Binding and Stability.
Tekijä: Laura Lori, et al.
Julkaistu: (2016-01-01)

BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stability
Tekijä: Jennings, L, et al.
Julkaistu: (2018)

[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.
Tekijä: Fedorov, O, et al.
Julkaistu: (2014)

The bromodomain interaction module.
Tekijä: Filippakopoulos, P, et al.
Julkaistu: (2012)

The bromodomain interaction module
Tekijä: Filippakopoulos, P, et al.
Julkaistu: (2012)

Developing small molecule inhibitors of the CREBBP bromodomain-histone interaction
Tekijä: Rooney, T, et al.
Julkaistu: (2012)

3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.
Tekijä: Hewings, D, et al.
Julkaistu: (2011)

Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762
Tekijä: Chaidos, A, et al.
Julkaistu: (2014)

Targeted protein degradation reveals BET bromodomains as the cellular target of Hedgehog pathway inhibitor-1
Tekijä: Meropi Bagka, et al.
Julkaistu: (2023-07-01)

3,5-Dimethylisoxazoles inhibit the bromodomain-histone protein-protein interaction
Tekijä: Hewings, D, et al.
Julkaistu: (2012)

Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer
Tekijä: Alison M. Kurimchak, et al.
Julkaistu: (2016-08-01)

BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications
Tekijä: Kenneth K. W. To, et al.
Julkaistu: (2023-03-01)

3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands
Tekijä: Hewings, D, et al.
Julkaistu: (2011)